{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:49Z","timestamp":1762521409601},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:p><jats:italic>Please cite this paper as:<\/jats:italic>Sharma M, Ortendahl J, van der Ham E, Sy S, Kim J. Cost\u2010effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand. BJOG 2012;119:166\u2013176.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold>To assess the health and economic outcomes of various screening and vaccination strategies for cervical cancer prevention.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold>Cost\u2010effectiveness analysis from a societal perspective.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold>Thailand.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold>Females aged 9\u2003years and older.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>Using a mathematical model of human papillomavirus (HPV) infection and cervical cancer, calibrated to epidemiological data from Thailand, we estimated the cost\u2010effectiveness of pre\u2010adolescent HPV vaccination, screening [visual inspection with acetic acid (VIA), HPV DNA testing, and cytology] between one and five times per lifetime in adulthood, and combined pre\u2010adolescent vaccination and screening. Vaccine efficacy, coverage, cost, and screening frequency were varied in sensitivity analyses.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold>Incremental cost\u2010effectiveness ratios, expressed as cost per year of life saved (YLS).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>Assuming lifelong efficacy and 80% coverage, pre\u2010adolescent HPV vaccination alone was projected to reduce the lifetime risk of cervical cancer by 55%, which was greater than any strategy of screening alone. When cost per vaccinated girl was I$10 (approximately $2 per dose) or less, HPV vaccination alone was cost saving. Pre\u2010adolescent vaccination and HPV DNA testing five times per lifetime, starting at age 35\u2003years, reduced the lifetime cervical cancer risk by 70%, and had a cost\u2010effectiveness ratio less than Thailand\u2019s GDP per capita (I$8100), provided the cost per vaccinated girl was I$200 or less.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold>Low cost pre\u2010adolescent HPV vaccination followed by HPV screening five times per lifetime is an efficient strategy for Thailand. Costs may need to be lower, however, for this strategy to be affordable. If vaccination is not feasible, HPV DNA testing five times per lifetime is efficient.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2011.02974.x","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T10:56:50Z","timestamp":1302605810000},"page":"166-176","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cost\u2010effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand"],"prefix":"10.1111","volume":"119","author":[{"given":"M","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ortendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"van der Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"e_1_2_11_2_2","unstructured":"WHO\/ICO Information Centre on HPV and Cervical Cancer Human Papillomavirus and Related Cancers in Thailand.Summary Report 2010. [www. who. int\/hpvcentre]. Last accessed 20 June 2010."},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a83dd0"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.039"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11530"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-8-23"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2009.09.001"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61195-7"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12707-9"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808516"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-8080(08)32401-X"},{"key":"e_1_2_11_12_2","unstructured":"TangcharoensathienV LimwattananonS ChaugwonR.Research for development of an optimal strategy for prevention and control of cervical cancer in Thailand. Research report submitted the World Bank. Nonthaburi: Ministry of Public Health Thailand.2008. [www.hitap.net\/index_en.php]. Last accessed 30 June 2010."},{"key":"e_1_2_11_13_2","first-page":"1048","article-title":"Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers","volume":"40","author":"Songthap A","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.19.1.125"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.05.058"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm086"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.038"},{"key":"e_1_2_11_18_2","unstructured":"WHO.WHO Life Tables 2008.2008[www.who.int\/healthinfo\/statistics\/mortality_life_tables\/en\/]. Last accessed 5 November 2010."},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/373901"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-5-11"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa044278"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604462"},{"key":"e_1_2_11_23_2","unstructured":"World Bank World Development Indicators WDI Online. [www.worldbank.org]. Last accessed 20 June 2010."},{"key":"e_1_2_11_24_2","unstructured":"World Health Organization Statistical Information System: CHOICE (Choosing Interventions that are Cost Effective) [www.who.int\/choice\/en\/]. Last accessed 17 June 2010."},{"key":"e_1_2_11_25_2","unstructured":"International Labour Organization (ILO). [www.ilo.org\/global\/lang\u2010en\/index.htm]. Last accessed 10 June 2010."},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.24.3107"},{"key":"e_1_2_11_27_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost\u2010Effectiveness in Health and Medicine","author":"Gold MR","year":"1996"},{"key":"e_1_2_11_28_2","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond MF","year":"1997"},{"key":"e_1_2_11_29_2","volume-title":"World Health Organization. Making Choices in Health: WHO Guide to Cost\u2010Effectiveness Analysis","author":"Edejer TT\u2010T","year":"2003"},{"key":"e_1_2_11_30_2","unstructured":"WHOGuidelines for estimating costs of introducing new vaccines into the national immunization system 2002. [http:\/\/whqlibdoc.who.int\/hq\/2002\/WHO_V&B_02.11.pdf]. Last accessed 29 July 2010."},{"key":"e_1_2_11_31_2","unstructured":"World Bank: International Bank for Reconstruction and Development\/World Bank Group.World Development Indicators. World population projections. [http:\/\/devdata.worldbank.org\/data\u2010query\/]. Last accessed 30 June 2010."},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.116"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2011.02974.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2011.02974.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T02:38:35Z","timestamp":1712371115000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2011.02974.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1471-0528.2011.02974.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2011.02974.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]},"assertion":[{"value":"2011-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}